Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Phase I trials evaluating J695 now under way

July 13, 1999

Celgene reports potent, specific immune responses for thalidomide analogues

July 13, 1999

Rapamune up for FDA advisory committee review in late July

July 12, 1999

Anti-CD154 antibody facilitates islet allograft survival in highly relevant preclinical model

July 12, 1999

P2X7 receptor antagonists described in recent patent literature

July 12, 1999

Human Genome Sciences discovery may lead to novel immunotherapies and vaccines

July 12, 1999

Vaxin develops technology for transdermal vaccine delivery

July 9, 1999

Combination vaccine more effective against Lyme disease

July 8, 1999

Cangene seeks approval of VZIG in Canada

July 8, 1999

Allotrap-1258, a rationally designed immunomodulating peptide for the prevention of GvHD

July 6, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...